VEMERIX
Medical Equipment
INSIGHTS

Research and practical buying guidance.

Browse practical buyer, technical, regulatory and evidence-led guidance across the VEMERIX knowledge library.

LATEST ARTICLES

Practical guidance from the VEMERIX team.

VEMERIX regulatory guide cover showing a sterile tube of silicone scar gel, silicone sheeting segment, and US EU China regulatory decision documentation.
Regulatory Guide
Silicone Scar Gel Classification and Claim Substantiation: A US (FDA), EU and China (NMPA) Decision Matrix for Distributors and OEM BuyersQualifying a silicone scar gel or sheeting product for international markets requires navigating strict claim-by-claim classification rules across the US (FDA Class I under 21 CFR 878.4025), Europe (EU MDR Class I device vs Cosmetic Regulation boundary), and China (NMPA Class II medical device filing)—where permitted intended-use language, Cochrane evidence certainty, and ISO 10993 biocompatibility requirements set the boundary between compliant commercialization and regulatory rejection.August 5, 2026 · 14 min read
VEMERIX technical guide cover showing an ISO 11137 radiation sterilization validation framework, VDmax decision table, and modality comparison.
Technical Guide
Radiation (Gamma, Electron-Beam and X-Ray) Sterilization Validation for Single-Use Medical Devices: An ISO 11137, VDmax and FDA Evidence Guide for OEM and Private-Label BuyersQualifying a radiation-sterilized single-use device OEM requires verifying an ISO 11137 validation protocol, substantiating the 25 kGy or 15 kGy sterilization dose via VDmax, selecting the optimal modality (gamma vs e-beam vs X-ray), capping polymer maximum doses, and aligning with the 4-month dose-audit interval under ISO 11137-1:2025 and the FDA Radiation Master File Pilot.August 4, 2026 · 18 min read
VEMERIX report cover showing a 1470 nm endovenous laser fiber specification and optical compatibility framework.
Buyer Guide
Endovenous Laser Fiber Specifications & Compatibility: A Buyer's Specification and RFQ Guide for 1470 nm Radial FibersA 1470 nm single-use endovenous laser fiber must be matched to the console on wavelength, connector standard (SMA905), core diameter, numerical aperture, tip geometry (radial 360° vs bare-tip), introducer French size, and regulator-cleared status (FDA GEX / 21 CFR 878.4810 Class II 510(k); NMPA Class II; EU MDR IIb). Verify console compatibility and clearance before committing volume.August 3, 2026 · 14 min read
VEMERIX technical guide cover showing an ISO 11135 EO sterilization validation acceptance framework and ISO 10993-7 residual limits.
Technical Guide
Ethylene Oxide Sterilization Validation for Single-Use Medical Devices: An ISO 11135 Process, ISO 10993-7 Residual and FDA Evidence Guide for OEM and Private-Label BuyersQualifying a sterile single-use device OEM demands a validated ISO 11135 process, documented ISO 10993-7 residual dissipation profiles below 4 mg EO / 9 mg ECH for limited contact, clear parametric or BI release protocols, and a regulatory change-control strategy under the FDA Sterilization Master File pilots.August 3, 2026 · 16 min read
VEMERIX regulatory guide cover showing a US, EU and China regulatory decision matrix for hypochlorous acid (HOCl) disinfectants.
Regulatory Guide
Hypochlorous Acid (HOCl) Disinfectant Classification: A US, EU and China Regulatory Decision Matrix for Medical-Device and Hygiene-Product BuyersProcuring hypochlorous acid (HOCl) disinfectants internationally requires recognizing that regulatory classification is governed by intended-use claims, concentration, and application site rather than chemical identity—navigating the US EPA pesticide vs FDA liquid sterilant split under PRN 98-2, ECHA Biocidal Products Regulation (BPR) active substance rules in Europe, and China's weixiaozheng hygiene licensing system.August 3, 2026 · 15 min read
VEMERIX evidence review cover comparing PVA vs PU foam materials, pore mechanics, and open vs closed-incision NPWT change intervals.
Evidence Review
Negative Pressure Wound Therapy Dressing Selection: What the PVA-versus-PU Foam, Pore-Size and Closed-Incision-versus-Open-Wound Evidence Actually SupportsNavigating NPWT dressing selection requires separating material mechanics from clinical healing claims—evaluating open-pore PU black foam (400–600 µm) for high-exudate granulation against hydro-retentive PVA white foam for sensitive wound beds, respecting the 48–72 hour open-wound change boundary, and understanding the FDA regulatory divide between open-wound (OMP) and closed-incision (QFC) devices.August 3, 2026 · 15 min read
VEMERIX report cover showing NPWT tender lot splits, FDA failure mode mapping, and supplier acceptance framework.
Buyer Guide
How to Specify a Negative Pressure Wound Therapy (NPWT) System: A Lot-by-Lot Tender, RFQ & Acceptance Checklist for Pumps, Dressings and Canisters (2026)A hospital procurement, health-system category management, or distributor team specifying negative pressure wound therapy (NPWT) should not issue a single bundled RFQ. Structure tenders into platform lots (acute heavy-duty, portable ambulatory, single-use/disposable, consumables, rental), map every pump performance and alarm requirement directly to documented FDA failure modes (leak, occlusion, canister overflow, power thermal cutoff), and demand a 6-part regulatory evidence pack (510(k), UDI, ISO 10993, IEC 60601-1, EO sterilization) before awarding volume.August 3, 2026 · 18 min read
An on-brand VEMERIX report cover: a single dressing shown as a ladder of regulatory classes, rendered in accent-pink linework on a clean off-white field.
Deep ResearchRegulatory Guide
The Line That Decides the Class: How a Wound Dressing's Claim — Not Its Chemistry — Sets Its Regulatory Class in the US, EU and ChinaIn wound and skin care the label claim, not the material, sets the regulatory class — and because most of the category is 510(k)-exempt in the United States, the public clearance record systematically under-describes who actually supplies it. A primary-source read of 31 FDA product codes, EU MDR Rule 4 and NMPA's 2022 catalogue change.July 27, 2026 · 27 min read
An on-brand VEMERIX report cover: four minimally-invasive device lines converging on a single registered single-use consumable, rendered as a minimal razor-and-blade motif in accent-pink linework on a clean off-white field.
Deep ResearchMarket Analysis
The Single-Use Turn: Why Four Minimally-Invasive Device Lines Are All Migrating From the Durable Machine to the Registered Consumable — and What It Means for How You SourceAcross four unrelated device lines — vein ablation, wound therapy, circumcision, aesthetic injection — the same shift recurs: the durable machine commoditizes and value migrates to the registered single-use consumable. One pattern, three economic engines, and one sourcing conclusion: buy the platform, not the SKU.July 20, 2026 · 21 min read